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Introduction
During development, the establishment of organised patterns
of tissues and cell types requires precise temporal and spatial
control of cell proliferation, differentiation and movement.
Extracellular protein ligands play a central role in cell-cell
signalling required for patterning by binding specific cell-
surface receptors and activating intracellular signal
transduction pathways. Such signals can act in an autocrine
manner to regulate the phenotype of the cells that generate the
signal or can act in a paracrine manner on cells adjacent to or
many cell diameters from the signalling source. An increasing
number of mechanisms have been shown to modulate precisely
the activity of intercellular signals, reflecting the importance of
levels of particular signals. For example, a single morphogen
can elicit differentiation of several distinct cell types at
different threshold concentrations. The amount or spatial
distribution of signalling activity can be regulated by:
movement of a signal away from a localised source; inhibition
of a widespread signal by localised extracellular antagonists;
or induction of specific extracellular antagonists by the signal
itself, creating a negative feedback loop (Moghal and
Sternberg, 1999; Perrimon and McMahon, 1999).
The control of bone morphogenetic protein (BMP) ligand
action is an excellent example of the modulation of cell-cell
signalling. BMPs bind to and activate serine/threonine kinase
receptors, leading to phosphorylation of SMAD transcription
factors (Moustakas et al., 2001). They are important regulators
of cell differentiation in many tissues and play a key role
during early embryogenesis as revealed by studies in Xenopus
showing that localised inhibition of BMP4 activity is required
for the formation of neural ectoderm and dorsal mesoderm (De
Robertis et al., 2000). This inhibition is mediated by multiple
polypeptide antagonists secreted by the Spemann organiser,
including follistatin, noggin and chordin, that bind to BMP4
and prevent its interaction with BMP receptor (Balemans and
Van Hul, 2002). Further aspects of the control of BMP activity
have been revealed by detailed studies of Xenopus chordin and
its Drosophila homologue, short gastrulation. Formation of a
complex between chordin and BMP4 blocks interaction of
ligand with BMP receptor; however, following cleavage of
chordin by the protease Xolloid, BMP4 is released and can
bind to receptor (Piccolo et al., 1997). Another protein, twisted
gastrulation, has a dual role in enhancing antagonism by
stabilising chordin-BMP4 binding, and in promoting BMP4
activity by destabilising the binding of chordin cleavage
fragments to BMP4 (Chang et al., 2001; Larrain et al., 2001;
Oelgeschlager et al., 2000; Ross et al., 2001; Scott et al.,
2001).
Following neural induction, BMP4 has a number of
important functions in the formation and differentiation of the
neural crest. This migratory population of cells contributes to
many tissues in the vertebrate embryo, including melanocytes,
Previous work has revealed that proteins that bind to bone
morphogenetic proteins (BMPs) and inhibit their signalling
have a crucial role in the spatial and temporal regulation
of cell differentiation and cell migration by BMPs. We
have identified a chick homologue of crossveinless 2, a
Drosophila gene that was identified in genetic studies as a
promoter of BMP-like signalling. Chick Cv-2 has a
conserved structure of five cysteine-rich repeats similar to
those found in several BMP antagonists, and a C-terminal
Von Willebrand type D domain. Cv-2 is expressed in the
chick embryo in a number of tissues at sites at which
elevated BMP signalling is required. One such site of
expression is premigratory neural crest, in which at trunk
levels threshold levels of BMP activity are required to
initiate cell migration. We show that, when overexpressed,
Cv-2 can weakly antagonise BMP4 activity in Xenopus
embryos, but that in other in vitro assays Cv-2 can increase
the activity of co-expressed BMP4. Furthermore, we find
that increased expression of Cv-2 causes premature onset
of trunk neural crest cell migration in the chick embryo,
indicative of Cv-2 acting to promote BMP activity at an
endogenous site of expression. We therefore propose that
BMP signalling is modulated both by antagonists and by
Cv-2 that acts to elevate BMP activity.
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peripheral nervous system and the head skeleton. The neural
crest is induced at the interface between neural epithelium
and surface ectoderm. They subsequently leave the
neuroepithelium by undergoing an epithelial-mesenchymal
transition and migrating away from the neural tube, initially in
the anterior and then in progressively more posterior parts of
the embryo (Kalcheim, 2000; Knecht and Bronner-Fraser,
2002). BMP4 has been implicated in multiple steps of neural
crest development: as a component of the signalling that
induces neural crest (Knecht and Bronner-Fraser, 2002), in
control of the onset of neural crest migration (Sela-Donenfeld
and Kalcheim, 1999), in apoptosis of cranial neural crest
(Graham et al., 1994) and later in the differentiation of neural
crest to sympathetic neurons (Anderson et al., 1997).
Modulation of the level of BMP4 activity appears to be
important for the onset of trunk neural crest migration in the
chick embryo. Following closure of the chick neural tube,
BMP4 expression occurs in premigratory neural crest at similar
levels along the anteroposterior (AP) axis, whereas the BMP4
antagonist noggin is expressed in a graded fashion – high
posterior and low anterior. The onset of neural crest cell
migration requires a threshold level of BMP4 activity, such that
the progressive decrease of noggin expression underlies the
anterior to posterior wave of migration (Sela-Donenfeld and
Kalcheim, 1999).
Although many modulators of BMP activity have been
identified, the function of only a subset has been established
in the early vertebrate embryo. Furthermore, these factors
appear to function by blocking BMP activity by interfering
with binding to the receptor. Here, we identify a chick
homologue of the Drosophila gene crossveinless 2 (cv-2) and
analyse whether it modulates BMP activity. cv-2 encodes a
protein with five cysteine-rich (CR) repeats found in BMP-
binding proteins and is expressed in a number of sites of
BMP4 action, including premigratory neural crest. In assays
in Xenopus embryos, Cv-2 can inhibit BMP4 activity,
consistent with previous work, suggesting that CR repeat
proteins act as BMP antagonists. However, in other assays
in Xenopus embryos, Cv-2 increases BMP4 activity.
Furthermore, elevated Cv-2 expression leads to premature
migration of trunk neural crest in the chick embryo, indicative
of increased BMP activity. We discuss the implications of
these findings for roles of Cv-2 in the modulation of BMP
activity and neural crest cell migration.
Materials and methods
Sequencing and sequence analysis
Clones were sequenced at the Advanced Biotechnology Centre
(Imperial College, London, UK). Sequences were analysed for
putative open reading frames using the MacVector (Oxford
Molecular). Nucleic acid and protein sequence similarity searches
were performed using the gapped BLAST algorithms accessed at
http://www.ncbi.nlm.nih.gov. Protein family searches (Pfam) were
performed at http://pfam.wustl.edu and http://www.tigr.org/tdb/.
Whole-mount in situ hybridisation
Linearised cDNAs were used to synthesise digoxigenin labelled
antisense RNA probes and in situ hybridisations performed using
‘Protocol Four’ as previously described (Xu and Wilkinson, 1998).
In Xenopus blastomere injection experiments, Xbra transcripts were
detected by in situ hybridisation and NBT/BCIP substrate, then
alkaline phosphatase was acid-inactivated (Jowett, 1998) and
fluorescein dextran lineage tracer detected using alkaline
phosphatase-conjugated anti-fluorescein antibody and Fast Red
substrate.
Generation of recombinant protein and
immunoprecipitation analysis
The production of recombinant protein was carried out using the
Drosophila Expression System (DES; Invitrogen). Cv-2-and chordin-
coding regions were isolated by PCR and each inserted into the
pMT/BIP/V5-HisA expression vector. Expression constructs were
(co-)transfected into Schneider 2 insect cells (S2) using the calcium
chloride technique (Invitrogen). Cell lysis, immunoprecipitation and
western blotting were performed as described (Henkemeyer et al.,
1994; Larrain et al., 2000a). Briefly, expressing cells were lysed with
2 ml PLC buffer, and cell debris removed by centrifugation. Protein
G-Sepharose beads, pre-incubated with mouse anti-Myc antibody
(Santa Cruz Biotechnology), were added to the samples and incubated
overnight at 4°C. The beads were pelleted, washed, boiled in 20 m l
loading buffer and then electrophoresed through 10% SDS
polyacrylamide gels under reducing conditions. The proteins were
electroblotted onto PDVF membranes and probed using the anti-V5
HRP conjugated antibody (1:5000).
Xenopus embryo manipulation
Synthesis of capped mRNA from cDNAs in pCS2 vector for in vivo
injection was carried out as previously described (Moon and
Christian, 1989). In some experiments, RNA was co-injected with
lysinated fluorescein dextran lineage tracer. Embryos staged
according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967)
were used either for animal cap explant experiments or fixed for in
situ hybridisation.
Animal cap explants were excised from stage 8-9 embryos that had
been injected with the appropriate RNA(s) and allowed to develop to
the desired stage. Total RNA was isolated using Trizol reagent (Gibco
BRL) and was treated with RQ1 DNase (Promega) to remove genomic
DNA contaminants according to supplier’s specifications. cDNA was
synthesised using MMLV RTase (Gibco BRL) and random primers
(Promega). The PCR reaction mix contained 100 m M of each dNTP,
13AmpliTaq buffer (Perkin Elmer), 1.5 mM MgCl2, 0.1 m g of each
primer, 1 m C 32P dCTP and 1.25 units AmpliTaq DNA Polymerase
(Perkin Elmer). PCR conditions of 25 cycles: 93 ° C for 30 seconds;
55° C for 1 minute; 72 ° C for 30 seconds. The PCR products were
detected by electrophoresis on polyacrylamide gels followed by au-
toradiography or using a phosphoimager for quantitative analysis.
Primer sequences used are as previously described (Domingos et al.,
2001; Hemmati-Brivanlou et al., 1994; Ruiz i Altaba and Melton,
1989):
NCAM, CACAGTTCCACCAAATGC, GGAATCAAGCG-
GTACAGA; BF-1, CCTCAACAAGTGCTTCGTCA, TAAAGGT-
GAGTCCGGTGGAG; muscle actin, GCTGACAGAATGCAGAAG,
TTGCTTGGAGGAGTGTGT; EF-1a , CAGATTGGTGCTGGATAT-
GC and ACTGCCTTGATGACTCCTAG; Xbra, CACCGAGAAG-
GAGCTGAAGGTTAG and TGCCACAAAGTCCAGCAGAACC.
Chick electroporations
Electroporation was carried out as previously described (Itasaki et al.,
1999) using Cv-2-coding region cloned into pCS2 vector, and pCIG
to express GFP. Briefly, after co-injection of pCS2Cv-2 and pCIG
(3:1) into the neural tube lumen one 25 msecond square wave pulse
of 25 mV was applied to the embryo using a pulse generator, the
embryo allowed to recover for 1 minute before being sealed with
parafilm, and re-incubated. The right side of the neural tube of stage
10–/11– embryos was electroporated and embryos dissected out 15
hours later at stage 16. The embryos were fixed in 4% PFA for 1 hour
at room temperature and whole-mount in situ hybridisation carried
out.
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Results
Identification and structure of a novel chick CR
domain gene
Using a chick embryo hindbrain cDNA library subtracted with
pregastrulation stage cDNA (Christiansen et al., 2001), we
identified in an in situ hybridisation screen a clone
corresponding to an mRNA with a dynamic expression pattern
in the dorsal neural tube. Sequencing of a full-length clone
obtained from a neurula stage chick embryo cDNA library
revealed that this clone encoded a polypeptide with an N-
terminal signal peptide and five cysteine-rich (CR) motifs
related to the Von Willebrand factor type C domain, and at the
C-terminal end a Von Willebrand factor type D domain (VWD)
(Fig. 1). CR motifs are found in a diverse group of proteins,
some of which, including chordin, have been shown to bind
BMPs via specific CR domains (Garcia Abreu et al., 2002;
Larrain et al., 2000b). The VWD domain is present in a
number of extracellular proteins, and may be involved in
multimerisation via disulphide crosslinks through a conserved
CGLCG motif (Fig. 1). The strongest sequence similarities are
with two proteins that contain CR and VWD motifs (Fig. 1):
Drosophila crossveinless 2 (cv-2), which has the same primary
structure of five CR repeats and a C-terminal VWD motif
(Conley et al., 2000); and kielin, which has 27 CR repeats and
a C-terminal VWD motif (Matsui et al., 2000). Genome and
cDNA database searching and sequence comparisons reveals a
single cv-2-related gene in the human and mouse, and the
structure and expression pattern of the mouse homologue has
recently been described (Coffinier et al., 2002). We have
therefore identified the chick homologue of Drosophila Cv-2,
which we designate Cv-2. Biochemical and functional studies
have suggested that a number of CR proteins, including
chordin and procollagen IIA, bind to and antagonise BMP4
activity by sequestering BMP4 from its receptor (Larrain et al.,
2000b). By contrast, cv-2 was identified as a gene that
promotes the activity of dpp (a Drosophila BMP homologue)
required for the formation of crossveins in the Drosophila wing
(Conley et al., 2000). We therefore set out to analyse potential
relationships between Cv-2 and BMP signalling: first, by
analysis of the expression pattern of Cv-2; and, second, by
testing effects of Cv-2 on BMP activity in in vitro and in vivo
assays.
Cv-2 expression
Cv-2 is expressed in a number of tissues during early chick
embryogenesis. During gastrulation and neurulation, Cv-2
transcripts are detected in mesoderm ventrolateral to the
primitive streak, as well as in dorsal neural tube of the
hindbrain and spinal cord (Fig. 2A-D,G,H). At stage 13,
expression is detected in the outflow tract of the heart, in the
posterior part of the otic vesicle, adjacent to the dorsal aorta
and in mesenchyme adjacent to the eye (Fig. 2E). By stage 19,
Cv-2 expression also occurs in intersomitic mesenchyme, in
nephrogenic mesenchyme and in sympathetic ganglia that are
forming adjacent to the dorsal aorta (Fig. 2F,I,J).
Fig. 1. Sequence of chick Cv-2.
Amino acid sequence alignment
of chicken, mouse, human and
Drosophila Cv-2 with the
ClustalW multiple sequence
alignment using the BLOSUM30
algorithm. Identical and
conserved amino acid
substitutions are boxed, the
former being identified by dark
shading. Protein motifs identified
by Pfam are coloured as follows:
secretory signal in light blue; CR
1-5, cysteine-rich motif in green;
VWFD, von Willebrand Factor
type D domain in red; and TIL,
trypsin inhibitor-like cysteine-rich
domain in purple. The black bars
highlight the amino acid sequence
CGLCG, a motif for potential
multimerisation by disulphide
crosslinking. GenBank Accession
Number AY731507.
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Many of these sites of cv-2 gene expression correlate with
regions of elevated BMP signalling (see Discussion), including
the dorsal neural tube from which neural crest cells migrate,
and the dorsal aorta adjacent to which they differentiate into
sympathetic ganglia. As there is evidence that BMP4 signalling
plays a role in these processes, we analysed Cv-2 expression
in neural crest in more detail. In the dorsal hindbrain, Cv-2
RNA is upregulated at stage 9– (Fig. 2A) and high levels are
maintained until stage 10 (Fig. 2B,C). By stage 10+ (Fig. 2D),
Cv-2 expression has been downregulated to low levels in the
hindbrain, and transcripts are localised to rhombomeres 3 and
5. Cv-2 expression occurs transiently and in a punctate pattern
in the dorsal midbrain and forebrain between stages 9 to 10
(Fig. 2B,C). In addition, an anterior to posterior wave of Cv-2
expression occurs in the dorsal spinal cord starting at stage 9
(Fig. 2B), such that, by stage 10+, Cv-2 expression has been
downregulated in the anterior trunk but is still expressed
posteriorly (Fig. 2D). Comparison of Cv-2 with slug, a marker
of premigratory neural crest cells (Fig. 2K-N), reveals that the
upregulation of Cv-2 expression occurs at the same time or
shortly after slug expression in the hindbrain and spinal cord,
and prior to the onset of neural crest emigration. By contrast,
Cv-2 expression occurs later than slug expression in the
midbrain and forebrain.
Binding and modulation of BMP4 activity by Cv-2
To test whether Cv-2 protein can bind to BMP4, we used an
expression system in Drosophila S2 cells to express V5
epitope-tagged Cv-2 protein or, as a positive control, V5-
tagged chordin. S2 cell lysates were mixed with BMP4 protein,
immunoprecipitated with anti-BMP4 antibody and a western
blot probed with anti-V5 antibody. We found that Cv-2 protein
co-immunoprecipitated with BMP4 protein (Fig. 3A).
We next investigated whether Cv-2 is an antagonist or
promoter of BMP4 signalling, and used the well-characterised
assays of RNA injections into Xenopus laevis embryos in
which the level of BMP activity affects axis formation, neural
induction and expression of mesodermal markers. Injection of
750 pg Cv-2 RNA into the dorsal blastomeres of four-cell stage
embryos does not affect embryo development (45/45 embryos),
but injection into ventral blastomeres leads to formation of a
partial secondary axis (25/69 embryos; Fig. 3B-E) or a
decreased body length (21/69 embryos; not shown). These
effects of Cv-2 are similar to the dorsalising activity of noggin,
but injection of 750 pg Cv-2 RNA was less potent than 25 pg
of noggin RNA (31/34 embryos strongly dorsalised; data not
shown), suggesting that Cv-2 acts as a weak antagonist of BMP
activity.
To further investigate an antagonist activity, we
microinjected Cv-2 RNA into the one-cell stage embryo
followed by the detection of neural gene expression in isolated
animal caps. Animal caps excised from stage 8 Xenopus
embryos and cultured in isolation form non-neural ectoderm.
Expression of BMP antagonists such as noggin in the animal
caps leads to formation of neural ectoderm, as revealed by
expression of the general neural marker NCAM and anterior
neural marker BF-1. Induction of NCAM and BF-1 in animal
caps does not occur following injection of increasing doses up
to 4 ng of Cv-2 RNA, whereas injection of 0.1 ng of noggin
RNA induces neural gene expression (Fig. 3F). However, co-
injection of 2 ng Cv-2 RNA was found to increase the induction
Development 131 (21) Research article
Fig. 2. Expression pattern of Cv-2 in the chick embryo. Whole-
mount in situ hybridisations of Cv-2 (A-F) and Slug (K-N) and
transverse sections of Cv-2 hybridised embryos (G-J). (A) HH stage
9– (seven-somite stage). Cv-2 expression is detected in posterior
lateral mesoderm (lm) and in premigratory neural crest (nc) in the
hindbrain and anterior spinal cord. (B) Stage 9 (eight somites). Cv-2
expression is upregulated in premigratory neural crest in the
hindbrain and spinal cord, and in some cells in the midbrain.
(C) Stage 9+ (10 somites). Expression seen at stage 9 persists but (D)
by stage 10+ (13 somites) Cv-2 expression in the hindbrain and
anterior spinal cord is downregulated. Low levels of Cv-2 expression
occur in the hindbrain in rhombomeres 3 and 5. (E) Stage 13. Cv-2
transcripts are detected at the posterior lip of the otic vesicle (ov), the
outflow tract of the heart (ot) and sclerotome surrounding the dorsal
aorta between the branchial arches (sc). (F) Stage 19. Cv-2
transcripts are detected in the intersomitic region (is), in sympathetic
ganglia (sg), in the outflow tract of the heart (ot) and in nephrogenic
mesenchyme (nm). (G,H) Transverse sections through the neural
tube of stage 9+ as indicted in C show that Cv-2 transcripts are
restricted to premigratory neural crest cells (nc) in the dorsal neural
tube. (I,J) Transverse sections through a stage 19 embryo, showing
Cv-2 expression in (I) sympathetic ganglia (sg) adjacent to the dorsal
aorta (da) and in (J) nephrogenic mesenchyme (nm) surrounding the
nephric ducts. (K-N) In situ hybridisation to detect slug transcripts, a
marker of premigratory and migrating neural crest from stage 9– to
stage 10+. Black arrowheads identify the midbrain/hindbrain
boundary, black arrows indicate the posterior limit of the hindbrain.
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of neural marker expression following injection of 0.1 ng
noggin RNA (Fig. 4G). Thus, in these assays Cv-2 does not
antagonise BMP4 activity sufficiently for neural induction to
occur, but can synergise with a strong BMP antagonist.
In RNA-injection experiments, expression of Cv-2 protein
is predicted to be at high levels in comparison with
endogenous BMPs. Because the relative levels of Cv-2 and
BMP proteins may influence BMP activity, we tested the
effect of co-expressing Cv-2 and BMP4 on the regulation of
a BMP-inducible gene. In one series of experiments, we used
an assay (Cui et al., 2001) in which injection of BMP4 RNA
into single animal pole blastomeres at the 32-cell stage
induces the ectopic expression of the Xbra gene. At stage 10.5,
Xbra expression is confined to the blastopore lip in uninjected
embryos (Fig. 4A). However, in embryos ectopically
expressing BMP4 or BMP4 plus Cv-2, ectopic expression of
Xbra occurs, either in a domain co-extensive with normal
Xbra expression around the blastopore lip (Fig. 4B,C) or as
an isolated domain (Fig. 4D). Injection of increasing doses of
BMP4 RNA, from 100 pg to 2 ng, led to ectopic Xbra
expression in an increasing proportion of embryos (Fig. 4E).
Co-injection of Cv-2 RNA increased the induction of Xbra
expression at each dose of BMP4, whereas Cv-2 injection
alone did not induce Xbra expression (Fig. 4E). For example,
200 pg BMP4 RNA plus 2 ng Cv-2 RNA is more potent than
a tenfold higher amount of BMP4 RNA alone.
Based upon these results with expression in whole embryos,
we then tested whether Cv-2 modulates the ability of BMP4 to
induce Xbra expression in isolated animal caps (Ohkawara et
al., 2002). Co-injection of 200 pg BMP4 RNA plus 200 pg Cv-
2 was found to induce a fourfold higher level of Xbra
expression compared with injection of 200 pg BMP4 RNA
alone (Fig. 4F). Taken together, these results suggest that Cv-
2 potentiates the effects of BMP signalling under these assay
conditions.
Modulation of BMP activity in chick neural crest
The results of ectopic expression assays in Xenopus embryos
raises the important issue of whether Cv-2 acts to inhibit or
enhance BMP activity at endogenous sites of expression. One
such site is in the dorsal neural tube from which neural crest
cells migrate. In this location, threshold levels of BMP
signalling are required for neural crest cell emigration, as
inhibition of BMP4 activity delays migration, thus causing an
anterior shift of the AP location at which migration is initiated
(Sela-Donenfeld and Kalcheim, 1999). We therefore tested
whether the onset of trunk neural crest migration could be
altered by increasing the protein levels of Cv-2 via
electroporation of an expression construct. Using Sox10 and
HNK1 as neural crest markers, we found that increased
expression of Cv-2 led to premature migration of neural crest,
at a location two to three somites more posterior than on the
Fig. 3. In vitro analysis of Cv-2 activity. (A) Western blot analysis and co-immunoprecipitation reveals the direct interaction of V5-tagged Cv-2
protein with recombinant human BMP4 protein. V5-tagged chordin is used as a positive control for BMP binding. (B-E) Effect of Cv-2
injection on axis formation in Xenopus at stage 14 (B) and stage 27 (C-E). Ventral injections of Cv-2 RNA induce a partial secondary axis
(arrows; B,C,E). Transverse section through the trunk of a stage 27 embryo injected ventrally with Cv-2 confirms the presence of an ectopic
secondary neural epithelium (arrow, D). (F,G) RT-PCR analyses of Xenopus animal cap explants. (F) Xenopus Noggin mRNA induces
expression of the general neural marker NCAM and anterior neural marker BF1. Increasing amounts of Cv-2 mRNA do not induce expression
of either neural marker. (G) Co-injection of 2 ng Cv-2 RNA plus 0.1 ng noggin RNA increases the induction of BF-1 when compared with
injection of 0.1 ng noggin RNA alone. The mesodermal marker muscle actin is used to confirm the absence of mesoderm in the explants and
elongation factor-1 alpha (EF-1a ) is used to assess the relative amounts of recovered mRNA.
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control non-electroporated side of the neural tube (9/16
embryos; Fig. 5C-E), whereas electroporation of empty vector
had no effect (Fig. 5A,B). This finding suggests that increased
expression of Cv-2 increases the effective level of BMP
activity.
The above experiments were performed at trunk levels. Cv-
2 is also expressed in premigratory neural crest cells in the
hindbrain region, where BMP4 has been proposed to promote
apoptosis in branchial neural crest (Graham et al., 1994).
However, overexpression of Cv-2 had no apparent effect on
apoptosis in this region (data not shown).
Discussion
We have identified chick Cv-2, a homologue of Drosophila
crossveinless-2, with a conserved structure of five CR repeats
and a C-terminal Von Willebrand type D domain. As genetic
studies show that crossveinless-2 promotes Dpp activity in the
Drosophila wing (Conley et al., 2000), it might be anticipated
that Cv-2 has an analogous role in vertebrate development in
promoting BMP activity. Indeed, Cv-2 is found in a number of
tissues that require high levels of BMP activity: in ventrolateral
mesoderm (Streit and Stern, 1999), premigratory neural crest
(Graham et al., 1994; Sela-Donenfeld and Kalcheim, 1999), the
outflow tract of the heart (Delot et al., 2003), nephrogenic
mesenchyme (Obara-Ishihara et al., 1999), and in sympathetic
ganglia (Schneider et al., 1999). In many of these tissues, such
as ventrolateral mesoderm and premigratory neural crest, Cv-
2 expression occurs within a subdomain of BMP4 expression.
In other locations, Cv-2 and BMP expression occurs in
adjacent tissues; for example, BMPs expressed in the dorsal
aorta induce differentiation of the sympathetic ganglia that
express Cv-2. The pattern of Cv-2 in chick is similar to that
described in a gene expression study of mouse Cv-2 (Coffinier
et al., 2002), and is consistent with the possibility that
vertebrate Cv-2 acts to elevate BMP activity. However, several
CR-containing proteins can antagonise BMP activity by
binding BMPs and sequestering them from BMP receptors
(Garcia Abreu et al., 2002; Larrain et al., 2000b; Matsui et al.,
2000). This therefore raises the issue of whether chick Cv-2
can increase and/or decrease BMP activity.
Antagonism and promotion of BMP4 activity
The Xenopus embryo is an important assay system for the
study of BMP antagonists, in which inhibition of endogenous
BMP activity leads to ectopic axis formation in whole
embryos, dorsalisation of mesoderm or neural induction in
animal caps. Such assays have revealed that a number of
proteins containing CR repeats such as chordin, procollagen
IIA and kielin can bind to and antagonise BMP4, suggesting a
general role of CR domain proteins in decreasing BMP activity
in vivo (Garcia Abreu et al., 2002; Larrain et al., 2000b).
Chordin is a strong antagonist that when ectopically expressed
dorsalises mesoderm and induces neural ectoderm (Piccolo et
al., 1996), consistent with its role as a component of the BMP
antagonist activity of the Spemann organiser. Procollagen IIA
has also been proposed to act an antagonist of BMP activity,
as ventral expression induces a secondary axis and dorsalises
explanted mesoderm (Larrain et al., 2000b). Similarly, ectopic
expression of kielin expands neural ectoderm in the embryo
and dorsalises mesoderm (Matsui et al., 2000). However, kielin
does not induce neural tissue in isolated animal caps, and it
was therefore proposed that the expansion of neural ectoderm
in the intact embryo could occur via the dorsalisation of
mesoderm that in turn expresses neural inducing signals
(Matsui et al., 2000). These findings are potentially relevant to
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Fig. 4. Elevation of BMP4 activity by Cv-2. (A-D) Injection of Cv-2
(A), BMP4 (B) or BMP4 plus Cv-2 mRNA (C,D) with fluorescein
dextran lineage tracer into a single animal pole blastomere at the 32-
cell stage embryo, and Xbra expression detected at stage 10.5.
Fluorescein dextran is detected in red, and Xbra in blue, with the
normal expression domain around the blastopore lip indicated with a
black ellipse. Ectopic BMP4 with or without Cv-2 induces ectopic
expression of Xbra, either co-extensive with the normal expression
around the blastopore lip (B,C) or as an isolated patch (D).
(E) Summary of the effects of BMP4 and Cv-2 injections on the
proportion of embryos with ectopic Xbra expression (%, y-axis). For
each amount of BMP4 RNA, co-injection of Cv-2 RNA increases the
induction of Xbra expression. The number of embryos analysed are
indicated at the top of the chart. (F) Injection of BMP4 and/or Cv-2
mRNA at the one-cell stage embryo, followed by excision of animal
caps at stage 8-9, and RT-PCR analysis of Xbra transcripts at stage
10.5. Quantitation with a phosphoimager reveals that Xbra
expression is fourfold higher in BMP4 plus CV-2 injected animal
caps than with BMP-4. Cv-2 alone does not induce Xbra expression.
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Cv-2, as kielin protein has a related structure of CR repeats and
a C-terminal VWD domain, and because, similar to kielin, we
find that overexpression of Cv-2 induces ectopic neural tissue
in the whole embryo, but not in animal caps. A difference is
that kielin does not induce a secondary axis, whereas Cv-2 can
do so. By analogy with the results of assays using individual
CR domains (Larrain et al., 2000b), this may reflect that
secondary axis formation requires a greater inhibition of BMP
activity than does dorsalisation without secondary axis
formation. A key question is why does Cv-2 inhibit BMP
activity in these assays, whereas in other assays Cv-2 can
increase BMP activity?
Our findings suggest that, when overexpressed, Cv-2 acts as
a weak antagonist that cannot decrease BMP activity
sufficiently to induce neural ectoderm in animal caps. The
antagonistic effects of Cv-2 are detected in experiments in
which overexpression of Cv-2 inhibits endogenous BMPs,
whereas we find that Cv-2 can promote BMP activity when co-
expressed with BMP4. Our findings are consistent with a
model in which there is competition between binding of BMP4
to unoccupied Cv-2 (not already bound to BMP4) or to BMP
receptor. When Cv-2 and BMP4 are present at similar levels,
there is a low amount of unoccupied Cv-2, and thus BMP4
released from Cv-2 will frequently bind to BMP receptor.
However, when Cv-2 is present in great excess over BMP4, the
equilibrium shifts such that BMP4 will more frequently bind
to unoccupied Cv-2 rather than to BMP4 receptor. One
interpretation of our findings is that Cv-2 could have a dual
role by decreasing the activity of low levels of BMP4, but
increasing the activity of higher levels of BMP4. Alternatively,
antagonism of BMP4 may be an effect of high levels of Cv-2
compared with BMP4 expression that do not occur in vivo.
There are similarities and differences between our results on
chick Cv-2 and a recent study of a mouse Cv-2 homologue
(Moser et al., 2003). Consistent with our results, expression of
mouse Cv-2 was found to bind BMPs, to dorsalise mesoderm
in activin-induced animal caps, and to induce secondary axis
formation following ventral overexpression in Xenopus
embryos. In addition, mouse Cv-2 antagonised the response to
recombinant BMP4 in cell culture assays. However, these
authors did not analyse neural induction in animal caps or carry
out assays that detected cooperation with co-expressed BMP4,
and consequently concluded that Cv-2 normally acts as an
antagonist. Although the results are consistent with our
findings that we interpret as a weak BMP antagonistic effect
of overexpressed Cv-2, an apparent discrepancy is that
expression of an excess of Cv-2 blocked the ability of BMP4
to ventralise the Xenopus embryo when expressed in dorsal
tissue. By contrast, we find that Cv-2 increases the activity of
co-expressed BMP4. However, we also find that overexpressed
Cv-2 can cooperate with noggin, a strong BMP antagonist, to
further block BMP activity. This may be due to the high ratio
of unoccupied Cv-2 to BMPs in this situation, or alternatively
it is possible that Cv-2 increases the binding of noggin to
BMP4 (but see below). The inhibition by Cv-2 of BMP-
Fig. 5. Effect of elevated Cv-2 expression on trunk neural crest cell
migration. (A-E) Representative images of the trunk region of stage
16 chick embryos electroporated with pCIG (A,B) or co-
electroporated with pD CS2Cv-2 and pCIG (C-E) expression
constructs at HH stage 10+. (A) In situ hybridisation with Sox10 of a
control pCIG electroporated embryo. (B) Transverse section of
embryo (A) at axial level indicated; black and white arrows identify
equal progression of Sox10-positive migratory neural crest cells on
control and electroporated sides. (C) In situ hybridisation with Sox10
of an embryo overexpressing Cv-2. The domain of Sox10 expression
extends further caudally on the side overexpressing Cv-2 (right) than
the control side (left). Insets in A and C show the distribution of
GFP-positive cells, demonstrating the domain and efficacy of the
electroporation prior to in situ hybridisation analysis; left side of the
neural tube is the control; right side is the electroporated side.
(D,E) Transverse sections through embryo (in C) as indicated by
lines, with immunofluorescence labelling of HNK1.
(D ¢ ,E¢ ) Corresponding bright-field images in which the Sox10 signal
is more easily seen. In the more anterior section (D,D¢ ) there is an
increase in the number and distance of migration of HNK-1-positive
migratory crest cells on the transfected side (black arrow) compared
with the control side (white arrow). Sox10 signal is not detected in
the ventral HNK1-expressing neural crest, perhaps owing to a
decreased level of expression during ventral migration. In the more
posterior section (E,E¢ ) Sox10- and HNK-1-positive crest cells have
initiated migration on the Cv-2 electroporated side (black arrow) but
not on the untreated side.
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induced ventralisation of dorsal tissues may therefore be
explained by cooperation between overexpressed Cv-2 and
endogenous BMP antagonists that are present in dorsal regions.
Roles of Cv-2 in premigratory neural crest
Previous work has shown that inhibition of BMP activity by a
posterior to anterior gradient of noggin controls the timing of
neural crest cell emigration in the trunk (Sela-Donenfeld
and Kalcheim, 1999). Neural crest migration is initiated
when noggin expression in premigratory neural crest is
downregulated by somite-derived signals (Sela-Donenfeld and
Kalcheim, 2000), such that a threshold level of BMP activity
is achieved. Expression of Cv-2 occurs in a broad domain in
premigratory neural crest that shifts in an anterior-to-posterior
wave and precedes the initiation of neural crest emigration.
Thus, the onset of neural crest migration is preceded by
an upregulation of Cv-2 and downregulation of noggin
expression. Furthermore, elevated expression of Cv-2 leads to
premature emigration of neural crest, consistent with Cv-2
acting to enhance BMP activity. This result argues that the
increased antagonism of endogenous BMPs in the presence
of noggin plus Cv-2 in Xenopus assays is an effect of
overexpression, and that at physiological levels of expression,
noggin and Cv-2 have opposite effects on BMP activity. We
therefore propose that the timing of neural crest cell migration
is regulated by the balance between the promotion of BMP
activity by Cv-2 and inhibition by noggin. This model raises
the question of how Cv-2 expression is controlled in trunk
neural crest, and whether it is downstream of the slug
transcription factor that regulates neural crest cell migration,
or whether, like noggin, Cv-2 expression is controlled by
signals from the adjacent somites.
BMP4 appears to have a distinct role in branchial compared
with trunk neural crest in the chick embryo, in which it
regulates the elevated apoptosis of neural crest cells derived
from rhombomeres r3 and r5 (Graham et al., 1994), and is
antagonised by noggin expression in r4 (Smith and Graham,
2001). The expression of Cv-2 in premigratory branchial
neural crest could underlie a promotion of BMP4 activity in
opposition to noggin, and intriguingly at late stages of
expression in the hindbrain, Cv-2 transcripts are restricted to
dorsal r3 and r5. Although we did not detect altered apoptosis
following ectopic expression of Cv-2, it is possible that this
reflects a lack of sensitivity of this response to any changes in
BMP4 activity, in contrast to the threshold levels required for
trunk neural crest migration. Alternatively, BMP4 may have an
indirect role in the apoptosis of branchial neural crest (Farlie
et al., 1999).
Potential mechanisms of Cv-2 action
Our findings provide the first evidence that vertebrate Cv-2
elevates BMP4 activity, similar to Drosophila cv-2, whereas
other studies of vertebrate Cv-2 and of related CR proteins had
only detected an antagonistic activity. Loss-of-function studies
will be required to determine whether Cv-2 has a dual role in
promoting and blocking BMP activity or normally acts only to
increase BMP activity. A key question is how Cv-2 promotes
BMP activity. As suggested for Drosophila cv-2 (Conley et
al., 2000), the presence of a VWD domain implicated in
multimerisation of extracellular matrix proteins raises the
possibility that Cv-2 binds to matrix and locally elevates BMP4
levels by constraining free diffusion into adjacent tissue; this
requires that Cv-2 can release BMP4 to BMP receptor and acts
as a ‘sponge’ rather than a ‘trap’ for BMP4. This model
predicts that Cv-2 activity can only be detected in the context
of spatially restricted BMPs, and can explain why Cv-2 does
not elevate BMP activity in cell culture experiments (Moser et
al., 2003). Furthermore, as BMP4 itself can bind to specific
extracellular matrix proteins (Ohkawara et al., 2002), the
ability of Cv-2 to modulate BMP activity may depend upon
which matrix proteins are present within the tissue.
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